摘要
动脉粥样硬化是心血管系统最常见的疾病,也是危害人类健康的常见病。随着分子生物学和病理生理学的发展,现已揭示动脉粥样硬化是一个可以被改善的动态过程。近年来在抗动脉粥样硬化方面,随着循证医学不断证明他汀类调脂药在抗动脉粥样硬化的确切作用及基因治疗的发展,抗动脉粥样硬化防治有了飞速发展,本文从药物及基因等方面简述动脉粥样硬化的防治。
Atherosclerosis is a common disease of cardiovascular system, which endangers human health. With the development of molecular biology and pathologic physiology, the atherosclerosis has been identified as a dynamic process which can be improved. In recent years, evidence-based medicine in anti-atherosclerosis showed the real efficacy of statin drugs in the anti-atherosclerosis and the development of gene therapy. Prevention and treatment of atherosclerosis have maken a big progress. This article reviews its prevention and treatment based on drug and gene therapy.
出处
《医学综述》
2009年第11期1657-1659,共3页
Medical Recapitulate
